The trimeric RBD version of the SARS-CoV-2 spike protein blocked SARS-CoV-2 binding to ACE2, thereby blocking viral infection (IC50 was 1.6 μg/mL) [48]. This evidence concerns the gene ACE2 and viral infectious disease.